STAT3 and cancer: These findings underscore the pivotal role of STAT3 in orchestrating immune evasion and systemic catabolism, positioning it as a promising therapeutic target for addressing both cancer progression and the immunometabolic dysfunctions characteristic of cancer cachexia.